Phase I Safety Study of Clostridium Novyi-NT Spores in Patients With Treatment-refractory Solid Tumour Malignancies
Phase of Trial: Phase I
Latest Information Update: 01 Feb 2016
At a glance
- Drugs Clostridium novyi-NT (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors BioMed Valley Discoveries
- 01 Mar 2015 Interim results in 5 patients published in the Annals of Oncology.
- 13 Jun 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 01 Sep 2013 New trial record